Abstract
This study investigated the influence of serotonergic neurons of the dorsal raphe nucleus (DRN) on the effect of 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone, obtained from a hydroethanolic extract (HE) from Kielmeyera coriacea Mart. (Clusiaceae) stems. Intra-DRN microinjection (0.25 μ l/30 s) of xanthone or 5-HT1A ligands and its associations were performed in rats submitted to the forced swimming (FST) and to the open field (OFT) tests. Xanthone (0.3, 0.6 or 0.9 pmol), WAY100635 (5-HT1A antagonist; 0.2, 0.4 or 0.8 nmol) or (+)pindolol (5-HT1A/1B/ßadrenergic antagonist; 0.2, 0.4 or 0.8 nmol) did not alter immobility time in the FST. The 5-HT1A agonist, (+)8-OH-DPAT (0.6, 0.8, or 1.0 nmol) increases the immobility time in higher dose. Associated treatment of WAY100635 (0.8 nmol) or (−) pindolol (0.4 nmol) and xanthone (0.3 pmol), produced an anti-immobility effect, showing a synergic effect. Xanthone (0.3 pmol) abolished the increase on immobility time produced by (+)8-OH-DPAT (1.0 nmol). WAY100635 (0.8 nmol) blocked the increase in immobility time produced by (+)8-OH-DPAT (1.0 nmol). Crossings number in the OFT was not altered by any tested compound or associated treatment. These results suggest that the serotonergic neurons of the DRN, through the 5-HT1A somatodendritic autoreceptors, are involved in the xanthone effects on FST.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
